The University of Melbourne
Browse

File(s) not publicly available

Reason: data file not attached

A feasibility study of lorazepam for anxiety in palliative care (LORAZEPAM Study)

Version 2 2023-05-17, 05:30
Version 1 2023-05-17, 05:14
dataset
posted on 2023-05-17, 05:30 authored by Dr Nicola Atkin, Professor Brian Le, Professor Jennifer Philip
Demographic data for 15 adult patients with advanced cancer or advanced life-limiting disease and persistent or recurrent anxiety causing clinically significant distress or functional impairment at time of enrolment. 11 patients randomised to regular lorazepam treatment arm, 4 randomised to placebo, and treated for up to 12 weeks. Data collected at baseline, week 1,2,4,8,12 and follow-up at week 16 unless early discontinuation. Data includes anxiety measures (HADS-A, PROMIS 7a short form, PGIC), functional status (AKPS), other symptoms (ESAS), health-related quality of life (EQ 5D 5L), sleepiness (ESS), other adverse events and feasibility outcome data (recruitment, retention, completion of assessments, survival, acceptability, burden).

History

Resource Type

Individual Participant Data (IPD)

Institution name

Peter MacCallum Cancer Centre

Place

Victoria, Australia

Contact Organisation

HeSANDA MACH Node

Contact Organisation Identifier

https://ror.org/01ej9dk98

Study Identifier

https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=ACTRN12620001143910

Date Collected

2021-04-06/2022-08-01

HeSANDA Version

HeSANDA 1.0.0

Usage metrics

    MACH HeSANDA Datasets

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC